A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...
A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the ...
A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...
New MRI technique simultaneously maps multiple structural, physiological and molecular biomarkers to characterize brain tumours and multiple sclerosis lesions ...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) welcomed nearly 8,000 attendees to its 2026 Annual Meeting in Los Angeles this week, with overall participation expected to reach well ...
Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...
Genomic and tumor microenvironment dynamics of brain metastases in breast cancer. ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus ...
BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results